BANGKOK -- Siam Bioscience, a Thai drugmaker owned by the royal family, has started the country's first production of a COVID-19 vaccine, using AstraZeneca's technology.
COVID vaccines
Thai king-owned biotech starts production of AstraZeneca vaccine
Plans call for exports to other ASEAN countries as soon as next month
A picture of the Thai royals stands near a Siam Bioscience factory outside Bangkok. © Reuters
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on COVID vaccines
